Researcher biography

John Upham is a clinical scientist and physician with longstanding research interests in the immunological basis of asthma and chronic lung disease, the role of dendritic cells in allergy and virus infections of the lung, and the development of novel approaches to treatment. He has published over 150 peer-reviewed journal articles and book chapters, has over 4600 citations and an 'H score' of 37. He regularly publish in the top international journals in the respiratory and allergy/immunology fields with 65 publications (43% of his career output) in the last 5 years alone. Notable recent papers have been published in Lancet and Lancet Respiratory Medicine. In the last 10 years he has secured over $24 million in research funding. John has been awarded 8 NHMRC Project grants (4 as CIA in the last 5 years), 2 NHMRC CRE ("Closing the gap in Indigenous Lung Health" and "Severe Asthma"), and 1 NHMRC Development Grant. He currently hold NHMRC grants of $7.5 million, including $2.96 million as CIA. John was regularly an invited (9x), plenary (3x) and Chair (9x) at national and international conferences in the last 5 years. In recognition of his international standing and influence in the field, he was elected Fellow of the American Academy of Allergy, Asthma & Immunology (2004) and the Thoracic Society of Australia and New Zealand (2015).

He is a previous recipient of an NHMRC Neil Hamilton Fairley Fellowship, and the Young Investigator Award, Thoracic Society of Australia & New Zealand (TSANZ). He has held NHMRC Practitioner Fellowships and multiple Program and Project Grants from the NHMRC.

After completing his medical and specialty training in Brisbane, he moved to Perth to complete a PhD, followed by post-doctoral studies at McMaster University in Canada. In 2007 moved to Brisbane to take up a Chair of Respiratory Medicine with the University of Queensland and Princess Alexandra Hospital.